Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the familial response to Methylphenidate treatment (Ritalin IR) in two aspects: ADHD symptom's improvement and side-effects development.


Clinical Trial Description

Attention Deficit/Hyperactivity Disorder (ADHD) is very prevalent and tends to continue from childhood to adult life. It's heritability is 76%. It was found that there is a greater ADHD prevalence in first-degree families of ADHD subjects- 4-6 times more than the general population. Pharmacological treatment is the first line treatment today in ADHD, in children and adults, and Methylphenidate (specially Ritalin IR) is the first medication given for the disorder. The study includes couples of first-degree family members, both diagnosed with ADHD. Subjects will receive Ritalin IR for 4 weeks and undergo several psychiatric and cognitive questionnaires at each time of the follow-up meeting (a total of 3). ;


Study Design


Related Conditions & MeSH terms

  • ADHD Predominantly Hyperactivity Type
  • ADHD Predominantly Inattentive Type
  • ADHD-not Other Specified
  • Attention Deficit Disorder with Hyperactivity
  • Attention Deficit/Hyperactivity Disorder Combined Type
  • Hyperkinesis

NCT number NCT01554046
Study type Interventional
Source Sheba Medical Center
Contact
Status Completed
Phase N/A
Start date October 2011
Completion date April 2014

See also
  Status Clinical Trial Phase
Completed NCT03190902 - Cognitive Impairment in Pediatric Onset Multiple Sclerosis N/A
Active, not recruiting NCT04090983 - Cognitive-Behavioral Therapy for Adults With Attention-Deficit/Hyperactivity Disorder Inattentive Presentation N/A
Not yet recruiting NCT06081348 - Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders Phase 2
Completed NCT05452954 - Psychosocial ADHD Interventions - Brief Parent Training N/A
Recruiting NCT04504890 - Ocular-vestibular Biomarker Identification for ADHD
Recruiting NCT06299189 - A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care N/A
Recruiting NCT04729439 - Technology-Enhanced Executive Functioning Intervention for ADHD Phase 1
Completed NCT01685281 - Study Comparing Two Doses of MG01CI and Placebo in Adults With Predominantly Inattentive Attention Deficit Hyperactivity Disorder Phase 2